Amarin Corp Plc (AMRN)

[zumantu]

NCE made less relevant by BO of OMTH for $433. IMO this proves that O3's Rx continues to be hot bed of interest and investment and the unexpected OMTH BO was seen as the price of admission regardless of NCE.

Now Amarin stands alone as the sole independent owner of the world's best O3 Rx, IP protected, supply chain established, and FDA approved

Its been a bit odf a rollercoaster rye past 12 months, but its about to get a whole lot better for us Longs

Docs are begining to see blood work proving its efficacy, Scripts are ramping, 25 more patents in pipeline, Combo study is going to rock Pharma land with reducton of LDL oxidation when combined with a statin to the point that any cardioligist will understand as meaningful and predictive of a reduction in CV events - regardless of Reduce-it - they wont wait - lives are at stake